Selective targeting of phosphodiesterases to develop potent antiparasitic drugs

Shahbaz M. Khan, Md Mukthar Mia, William H. Witola

Research output: Contribution to journalShort surveypeer-review

Abstract

Regulation of intracellular cyclic nucleotides to avoid homeostatic imbalances is achieved through catabolic activity of phosphodiesterases (PDEs). Recently, Ajiboye et al. reported validation of Cryptosporidium PDE1 (CpPDE1) as a viable drug target and identified optimized pyrazolopyrimidines with selective activity against CpPDE1 over human PDEs and with potent anticryptosporidial efficacy.

Original languageEnglish (US)
Pages (from-to)1075-1076
Number of pages2
JournalTrends in Parasitology
Volume40
Issue number12
DOIs
StatePublished - Dec 2024

Keywords

  • Cryptosporidium
  • cyclic-nucleotides
  • drug-target
  • phosphodiesterases
  • pyrazolopyrimidines
  • selective-inhibition

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Selective targeting of phosphodiesterases to develop potent antiparasitic drugs'. Together they form a unique fingerprint.

Cite this